These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18799467)

  • 1. Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
    Lund IK; Jögi A; Rønø B; Rasch MG; Lund LR; Almholt K; Gårdsvoll H; Behrendt N; Rømer J; Høyer-Hansen G
    J Biol Chem; 2008 Nov; 283(47):32506-15. PubMed ID: 18799467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
    Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
    Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR
    PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.
    Botkjaer KA; Fogh S; Bekes EC; Chen Z; Blouse GE; Jensen JM; Mortensen KK; Huang M; Deryugina E; Quigley JP; Declerck PJ; Andreasen PA
    Biochem J; 2011 Aug; 438(1):39-51. PubMed ID: 21635223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
    Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
    J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase mediates fibrinolysis in the pulmonary microvasculature.
    Bdeir K; Murciano JC; Tomaszewski J; Koniaris L; Martinez J; Cines DB; Muzykantov VR; Higazi AA
    Blood; 2000 Sep; 96(5):1820-6. PubMed ID: 10961882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo.
    Lund IK; Rasch MG; Ingvarsen S; Pass J; Madsen DH; Engelholm LH; Behrendt N; Høyer-Hansen G
    Front Pharmacol; 2012; 3():122. PubMed ID: 22754528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.
    Ellis V; Danø K
    J Biol Chem; 1993 Mar; 268(7):4806-13. PubMed ID: 8444857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
    Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
    Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
    Chintala SK
    Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
    Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
    Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects.
    Reichel CA; Hessenauer ME; Pflieger K; Rehberg M; Kanse SM; Zahler S; Krombach F; Berghaus A; Strieth S
    PLoS One; 2015; 10(2):e0116883. PubMed ID: 25658820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.